Hoyeraal Hreidarsson SyndromeSymptoms, Doctors, Treatments, Advances & More
Learn About Hoyeraal Hreidarsson Syndrome
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Bassett Oneonta Specialty Services
Marina Bravin is a Dermatologist practicing medicine in Oneonta, New York. Dr. Bravin is rated as an Advanced provider by MediFind in the treatment of Hoyeraal Hreidarsson Syndrome. She is also highly rated in 59 other conditions, according to our data. Her clinical expertise encompasses Actinic Keratosis, Melanoma, Warts, and Psoriasis. Dr. Bravin is board certified in Internal Medicine, American Board Of Internal Medicine.
Clear Dermatology LLC
Jessica Galvin is a Dermatologist practicing medicine in Sinking Spring, Pennsylvania. Dr. Galvin is rated as an Experienced provider by MediFind in the treatment of Hoyeraal Hreidarsson Syndrome. Her clinical expertise encompasses Pityriasis Lichenoides Et Varioliformis Acuta, Pityriasis Lichenoides, Actinic Keratosis, and Graham-Little-Piccardi-Lassueur Syndrome. Dr. Galvin is board certified in American Osteopathic Board Of Dermatology.
Dermatology Clinic At Lauritzen Outpatient Center
Jennifer Adams is a Dermatologist practicing medicine in Omaha, Nebraska. She has been practicing medicine for over 13 years. Dr. Adams is rated as an Experienced provider by MediFind in the treatment of Hoyeraal Hreidarsson Syndrome. She is also highly rated in 1 other condition, according to our data. Her clinical expertise encompasses Actinic Keratosis, Warts, Graham-Little-Piccardi-Lassueur Syndrome, and Basal Cell Skin Cancer.
Summary: The goal of this clinical trial is to learn if a combination therapy of deoxycytidine (dC) plus deoxythymidine (dT) is safe in patients with telomere biology disorders. The main questions it aims to answer are: * Is the therapy safe with tolerable side effects in patients with telomere biology disorders? * Are problems with the bone marrow or blood or lungs changed after 6 months of dC+dT treatmen...
Summary: Phase II prospective trial to assess the rates of donor engraftment using reduced intensity conditioning (RIC) hematopoietic stem cell transplant (HSCT) and post-transplant cyclophosphamide (PTCy) for patients with primary immune deficiencies (PID), immune dysregulatory syndromes (IDS), inherited bone marrow failure syndromes (IBMFS), short telomere syndromes, Fanconi anemia, and non-Fanconi DNA d...